跳至主要内容
临床试验/JPRN-UMIN000001301
JPRN-UMIN000001301已完成未知

A prospective,randomized,single-blind,comparative study of Inslow,palatinose-based liquid formula and Meibalance,standard balanced liquid formula,using viscera fat accumulation as a primary endpoint in adults patients with confirmed diagnosis of obesity and impaired glucose tolerance. - A prospective,randomized,single-blind,comparative study of Inslow,palatinose-based liquid formula and Meibalance,standard balanced liquid formula ingested for a certain period,using visceral fat accumulation as a primary endpoint in adults patients with obesity and impaired glucose tolerance.

Meiji Dairies Corporation0 个研究点目标入组 50 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Participants recieveing anti-diabetic drug 2.Deep chronic drinker 3.Participants with following complications or with past histry *Exocrine diseases of pancreas: Pancreatitis;Tumor; Hemochromatosis,etc. *Endocrine diseases: Cushings's syndrome;Acromegaly, Pheochromocytoma; Hyperthyroidism,etc. *Hepatic diseases:Chronic hepatitis, Hepatic cirrhosis *Patients with gastrectmy or with chronic gastro-enteral disease 4.Female who is pregnant, in a lactation period, child-bearing potential or wishing to be pregnant. 5.Participants judged to be inadequate by the investigator.

研究者

发起方
Meiji Dairies Corporation

相似试验